Soleno Therapeutics Inc (SLNO) Stock
SLNO is no longer traded. Soleno Therapeutics was acquired by Neurocrine Biosciences (NBIX) in May 2026.
Prices on this page are historical; the last trade was May 15, 2026 at $53.01.
See Neurocrine Biosciences (NBIX) stock →Soleno Therapeutics stock price history
SLNO final trading statistics
- Final close
- $53.01
- Final trading day
- May 15, 2026
- Market cap at delisting
- $2.76B
- Shares outstanding
- 52.12M
- Final 52-week range
- $29.43 – $90.32
- Avg. volume (final 3 mo.)
- 3,411,767
- All-time high (split-adj.)
- $656.25 · Mar 2015
- All-time low (split-adj.)
- $0.89 · Dec 2022
- Return since IPO
- -81.8%
- Beta
- -2.22
- Book value / share
- $8.61
- Price / book
- 6.16
Soleno Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $190.41M | $20.9M | $0.23 |
| FY2024 | $0.00 | -$175.8M | -$4.26 |
| FY2023 | $0.00 | -$39.0M | -$2.97 |
| FY2022 | $0.00 | -$24.1M | -$3.32 |
| FY2021 | $0.00 | -$30.9M | -$5.85 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Soleno Therapeutics Inc
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California. As of May 18, 2026, Soleno Therapeutics, Inc. operates as a subsidiary of Neurocrine Biosciences, Inc.
Soleno Therapeutics stock FAQ
What happened to Soleno Therapeutics stock?
Soleno Therapeutics was acquired by Neurocrine Biosciences (NBIX) in May 2026. SLNO stock stopped trading on the Nasdaq, with a final close of $53.01 on May 15, 2026.
Is SLNO stock still trading?
No. SLNO was delisted from the Nasdaq in May 2026 and no longer trades on a U.S. exchange.
What was the last price of SLNO stock?
SLNO closed at $53.01 on its final trading day, May 15, 2026, for a market value of about $2.76B.
What were Soleno Therapeutics's revenue and earnings in its last full fiscal year?
Soleno Therapeutics reported revenue of $190.41M and net income of $20.9M in fiscal 2025, its last full year as a public company.
When did Soleno Therapeutics go public?
Soleno Therapeutics Inc stock began trading on November 13, 2014.